Drug search by name

Piqray 250MG Daily Dose and Cutaneous manifestations

Result of checking the interaction of drug Piqray 250MG Daily Dose and disease Cutaneous manifestations for safety when used together.

Check result:

Piqray 250MG Daily Dose <> Cutaneous manifestations

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Severe cutaneous reactions, including Stevens-Johnson Syndrome (SJS) and Erythema Multiforme (EM) were reported in patients treated with alpelisib. Do not initiate alpelisib treatment in patients with a history of SJS, EM, or Toxic Epidermal Necrolysis (TEN). If signs or symptoms of severe cutaneous reactions occur, interrupt treatment until the etiology of the reaction has been determined. Consultation with a dermatologist is recommended. If SJS, TEN, or EM is confirmed, permanently discontinue alpelisib. Do not reintroduce alpelisib in patients who have experienced previous severe cutaneous reactions during treatment.

Piqray 250MG Daily Dose

Generic Name: alpelisib

Brand Name: Piqray

Synonyms: Alpelisib

What is Piqray 250MG Daily Dose?